AbCellera Biologics Inc. ABCL United States — Total Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s united states — total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s united states — total revenue?
- AbCellera Biologics Inc. (ABCL) reported united states — total revenue of $2.78M in Q4 2025.
- How has AbCellera Biologics Inc.'s united states — total revenue changed year-over-year?
- AbCellera Biologics Inc.'s united states — total revenue increased by 311.1% year-over-year, from $675K to $2.78M.
- What is the long-term trend for AbCellera Biologics Inc.'s united states — total revenue?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s united states — total revenue has grown at a -15.5% compound annual growth rate (CAGR), from $21.8M to $11.1M.
- What does united states — total revenue mean?
- This metric represents the total gross income generated from operations within the United States geographic region. It reflects the company's ability to monetize its platform services and partnership agreements specifically within the domestic market. Tracking this figure helps investors assess the geographic concentration of revenue and the success of regional business development efforts.